Skip to contentBURRIS MICHELLE — ADAPTEC INC insider: 145 transactions · InsiderLensBURRIS MICHELLE
- Director at SONUS PHARMACEUTICALS INC · on record since May 15, 2006
- Senior V.P. and C.O.O. at Trubion Pharmaceuticals, Inc · on record since Feb 1, 2010
- CFO at SONUS PHARMACEUTICALS INC · on record since Jan 4, 2011
- Sr. Vice President, CFO at CORIXA CORP · on record since Jan 5, 2004
- Director at PHASERX, INC. · on record since May 17, 2016
- Director at PharmaFrontiers Corp. · on record since Sep 21, 2017
- Director at HTG MOLECULAR DIAGNOSTICS, INC · on record since Aug 17, 2018
- Director at ADAPTEC INC · on record since Jun 26, 2019
- Director at ADURO BIOTECH, INC. · on record since Oct 7, 2020
- Director at DENDREON CORP · on record since Dec 15, 2005
- CFO, SVP of Fin. & Treasure at DENDREON CORP · on record since Dec 15, 2005
Insider trading activity of BURRIS MICHELLE
- Transactions on record
- 145
- since Jan 5, 2004
- Open-market buys
- 0
- Open-market sells
- 25
- $4.8M
- Companies traded
- 9
- last filing Jun 29, 2026
Figures computed from official regulatory filings — methodology.
Companies where BURRIS MICHELLE has traded
- ADAPTEC INC67 tx · $5.6M · Jun 29, 2026
- ADURO BIOTECH, INC.10 tx · $1.1M · Aug 11, 2023
- PharmaFrontiers Corp.6 tx · Mar 16, 2023
- HTG MOLECULAR DIAGNOSTICS, INC6 tx · Sep 15, 2022
- PHASERX, INC.2 tx · May 30, 2017
- SONUS PHARMACEUTICALS INC11 tx · $105.6K · May 10, 2012
- Trubion Pharmaceuticals, Inc9 tx · Oct 28, 2010
- DENDREON CORP3 tx · Dec 15, 2005
- CORIXA CORP31 tx · Jul 14, 2005
Track record of BURRIS MICHELLE
Insufficient history for a statistical track record (fewer than 5 open-market buys).
Transaction history of BURRIS MICHELLE
Co-insiders of BURRIS MICHELLE
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
HERSHBERG ROBERTADAPTEC INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Jun 29, 2026 | ExerciseD | -52,084 | 0.00 USD | — | SEC |
| Jun 29, 2026 | Sell | -52,084 | 20.18 USD | — | SEC |
| Jun 29, 2026 | Exercise | 52,084 | 7.80 USD | — | SEC |
| Mar 13, 2026 | Sell | -15,394 | 13.91 USD | $214.1K | SEC |
| Mar 6, 2026 | Award | 15,625 | 0.00 USD | $0 | SEC |
| Mar 5, 2026 | Exercise | 48,044 | 3.99 USD | $191.7K | SEC |
| Mar 5, 2026 | ExerciseD | -48,044 | 0.00 USD | $0 | SEC |
| Mar 5, 2026 | Sell | -48,044 | 15.30 USD | $735.1K | SEC |
| Mar 17, 2025 | Sell | -36,291 | 7.19 USD | $260.9K | SEC |
| Mar 6, 2025 | AwardD | 23,726 | 0.00 USD | $0 | SEC |
| Mar 6, 2025 | Sell | -15,664 | 7.94 USD | $124.4K | SEC |
| Mar 6, 2025 | Award | 15,394 | 0.00 USD | $0 | SEC |
| Mar 6, 2024 | AwardD | 48,044 | 0.00 USD | $0 | SEC |
| Mar 6, 2024 | Award | 31,328 | 0.00 USD | $0 | SEC |
| Aug 11, 2023 | OtherD | -5,948 | 23.19 USD | $137.9K | SEC |
| Aug 11, 2023 | OtherD | -13,300 | 26.12 USD | $347.4K | SEC |
| Aug 11, 2023 | OtherD | -23,522 | 25.23 USD | $593.5K | SEC |
| Aug 11, 2023 | Other | -3,300 | — | — | SEC |
| May 31, 2023 | ExerciseD | -3,300 | 0.00 USD | $0 | SEC |
| May 31, 2023 | Exercise | 3,300 | — | — | SEC |
| Mar 29, 2023 | Sell | -2,341 | 8.49 USD | $19.9K | SEC |
| Mar 16, 2023 | AwardD | 20,000 | 0.00 USD | $0 | SEC |
| Mar 8, 2023 | AwardD | 23,329 | 0.00 USD | $0 | SEC |
| Mar 8, 2023 | Award | 14,775 | 0.00 USD | $0 | SEC |
| Sep 15, 2022 | AwardD | 4,000 | 0.00 USD | $0 | SEC |